Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis

Chemico-Biological Interactions

Volumn 180, Issue 2, 2009, Pages 271-280

  Sriram, Narayanan ^a   Kalayarasan, Srinivasan ^a   Sudhandiran, Ganapasam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Bleomycin; EGCG; Glycoconjugates; Lysosomal hydrolases; Pulmonary fibrosis; Ultrastructural changes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BLEOMYCIN; EPIGALLOCATECHIN GALLATE; FUCOSE; HEXOSAMINE; HEXOSE; HYDROLASE; HYDROXYPROLINE; LACTATE DEHYDROGENASE; LYSOSOME ENZYME; SIALIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG FIBROSIS; MALE; NONHUMAN; RAT; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CATECHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; L-LACTATE DEHYDROGENASE; LUNG; MALE; PULMONARY FIBROSIS; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 67349213581     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.02.017     Document Type: Article

References (69)

1. Kuhn C. The pathogenesis of pulmonary fibrosis. Monogr. Pathol. 36 (1993) 78-92
2. Crouch E. Pathobiology of pulmonary fibrosis. Am. J. Physiol. 259 (1990) L159-L184
3. Labat-Robert J., and Robert L. Interactions between structural glycoproteins and collagen. In: Nimni M.E. (Ed). Collugen (1988), CRC Press Inc., Boca Raton, FL 173-186
4. Berenson G.S., Radhakrishnamurthy B., Srinivasan S.R., Vijayagopal P., Dalferes Jr. E.R., and Sharma C. Recent advances in molecular pathology. Carbohydrate-protein macromolecules and arterial wall integrity-a role in atherogenesis. Exp. Mol. Pathol. 41 (1984) 267-287
5. Barrett A.J. Cellular proteolysis. An overview. Ann. N. Y. Acad. Sci. 674 (1992) 1-15
6. Lah T.T., Babnik J., Schiffmann E., Turk V., and Skaleric U. Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease. J. Periodontol. 64 (1993) 485-491
7. Chapman Jr. H.A., Munger J.S., and Shi G.P. The role of thiol proteases in tissue injury and remodeling. Am. J. Respir. Crit. Care Med. 150 (1994) 155-159
8. Wolters P.J., and Chapman H.A. Importance of lysosomal cysteine proteases in lung disease. Respir. Res. 1 (2000) 170-177
9. Cooper Jr. J.A., White D.A., and Matthay R.A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am. Rev. Respir. Dis. 133 (1986) 321-340
10. Osanai K., Takahashi K., Sato S., Iwabuchi K., Ohtake K., Sata M., and Yasui S. Changes of lung surfactant and pressure volume curve in bleomycin-induced pulmonary fibrosis. J. Appl. Physiol. 70 (1991) 1300-1308
11. Zia S., Hyde D.M., and Giri S.N. Development of a bleomycin hamster model of subchronic lung fibrosis. Pathology 24 (1992) 155-163
12. Usuki J., and Fukuda Y. Evolution of three patterns of intra-alveolar fibrosis produced by bleomycin in rats. Pathol. Int. 45 (1995) 552-564
13. Sriram N., Kalayarasan S., and Sudhandiran G. Enhancement of antioxidant defense system by epigallocatechin-3-gallate during bleomycin-induced experimental pulmonary fibrosis. Biol. Pharm. Bull. 31 (2008) 1306-1311
14. Tedeschi E., Suzuki H., and Menegazzi M. Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann. N. Y. Acad. Sci. 973 (2002) 435-437
15. Chen J.H., Tipoe G.L., Liong E.C., So H.S., Leung K.M., Tom W.M., Fung P.C., and Nanji A.A. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am. J. Clin. Nutr. 80 (2004) 742-751
16. Blanco A.R., Sudano-Roccaro A., Spoto G.C., Nostro A., and Rusciano D. Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob. Agents Chemother. 49 (2005) 4339-4343
17. Kang W.S., Lim I.H., Yuk D.Y., Chung K.H., Park J.B., Yoo H.S., and Yun Y.P. Antithrombotic activities of green tea catechins and (-)-epigallocatechin gallate. Thromb. Res. 96 (1999) 229-237
18. Lossos I.S., Izbicki G., Or R., Goldstein R.H., and Breuer R. The effect of suramin on bleomycin-induced lung injury. Life Sci. 67 (2000) 2873-2881
19. Chen F., Gong L., Zhang L., Wang H., Qi X., Wu X., Xiao Y., Cai Y., Liu L., Li X., and Ren J. Short courses of low dose dexamethasone delay bleomycin-induced lung fibrosis in rats. Eur. J. Pharmacol. 536 (2006) 287-295
20. N. Sriram, S. Kalayarasan, G. Sudhandiran, Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm. Pharmacol. Ther., in press doi:10.1016/j.pupt.2008.12.010.
21. Wang H.D., Yamaya M., Okinaga S., Jia Y.X., Kamanaka M., Takahashi H., Guo L.Y., Ohrui T., and Sasaki H. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am. J. Respir. Crit. Care Med. 165 (2002) 406-411
22. Neuman R.E., and Logan M.A. The determination of collagen and elastin in tissues. J. Biol. Chem. 186 (1950) 549-556
23. Wang H.C., Shun C.T., Hsu S.M., Kuo S.H., Luh K.T., and Yang P.C. Fas/Fas ligand pathway is involved in the resolution of type II pneumocyte hyperplasia after acute lung injury: evidence from a rat model. Crit. Care Med. 30 (2002) l528-1534
24. King J. The transaminase; alanine and aspartate transaminases. Practical Clinical Enzymology (1965), D. Van Nostrand Co., London pp. 363-395
25. King J. The hydrolases-acid and alkaline phosphatases. Practical Clinical Enzymology (1965), D. Van Nostrand Co., London pp. 199-208
26. King J. Lactate dehydrogenase. Practical Clinical Enzymology (1965), D. Van Nostrand Co., London pp. 83-93
27. McKenzie D., and Henderson A.R. Electrophoresis of lactate dehydrogenase isoenzymes. Clin. Chem. 29 (1983) 189-195
28. Niebes P. Determination of enzymes and degradation products of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin. Chim. Acta 42 (1972) 399-408
29. Wagner W.D. A more sensitive assay discriminating galactosamine and glucosamine in mixtures. Anal. Biochem. 94 (1979) 394-396
30. Warren L. The thiobarbituric acid assay of sialic acid. J. Biol. Chem. 234 (1959) 1971-1975
31. Dische L., and Shettles L.B. Specific colour reactions of methyl pentoses and spectrophotometric method for their determination. J. Biol. Chem. 175 (1948) 595-604
32. Meloan S.N., Valentine L.S., and Puchtler H. On the structure of carminic acid and carmine. Histochemie 27 (1971) 87-95
33. Wattiaux R., Jamieson G.A., and Robinson D.M. Mammalian Cell Membranes. 2nd ed. (1977), Butter Worth, London p. 165
34. Kawai Y., and Anno K. Mucopolysacharide-degrading enzymes from the liver of the squid Ommastrephes solani pacificus. I. Hyaluronidase. Biochim. Biophys. Acta 242 (1971) 428-436
35. Conchie J., Gelman A.L., and Levvy G.A. Inhibition of glycosidase by aldonolactones of corresponding configuration. The C-4 and C-6 specificity of beta glucosidase and beta-galactosidase. Biochem. J. 103 (1967) 609-615
36. Moore J.C., and Morris J.E. A simple automated colometric method for determination of N-acetyl β-d-glucosaminidase. Ann. Clin. Biochem. 19 (1982) 157-159
37. Sapolsky A.L., Altman R.D., and Howell D.S. Cathepsin D activity in normal and osteoarthritic human cartilage. Fed. Proc. 32 (1973) 1489-1493
38. Chen A., Zhang L., Xu J., and Tang J. The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem. J. 368 (2002) 695-704
39. Hagadorn J.E., Bloor C.M., and Yang M.S. Elevated plasma activity of lactate dehydrogenase isoenzyme-3 (LDH3) in experimentally induced immunologic lung injury. Am. J. Pathol. 64 (1971) 575-581
40. Rawson N.S., and Peto J. An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research. Br. J. Cancer 61 (1990) 597-604
41. Harada T., Koyama I., Shimoim A., Alpers D.H., and Komoda T. Identification of pulmonary surfactant that bears intestinal-type and tissue-nonspecific-type alkaline phosphatase in endotoxin-induced rat bronchoalveolar fluid. Cell Tissue Res. 307 (2002) 69-77
42. Capelli A., Lusuardi M., Cerutti C.G., and Donner C.F. Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders. Am. J. Respir. Crit. Care Med. 155 (1997) 249-253
43. Cobben N.A., Drent M., Jacobs J.A., Schmitz M.P., Mulder P.G., Henderson R.F., Wouters E.F., and van Dieijen-Visser M.P. Relationship between enzymatic markers of pulmonary cell damage and cellular profile: a study in bronchoalveolar lavage fluid. Exp. Lung Res. 25 (1999) 99-111
44. Matusiewicz S.P., Williamson I.J., Sime P.J., Brown P.H., Wenham P.R., Crompton G.K., and Greening A.P. Plasma lactate dehydrogenase, a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis. Eur. Respir. J. 6 (1993) 1282-1286
45. Kalayarasan S., Sriram N., and Sudhandiran G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-κB, TNF-α and IL-1β. Life Sci. 82 (2008) 1142-1153
46. Mason R.P., Walter M.F., and Mason P.E. Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis. Free Radic. Biol. Med. 23 (1997) 419-425
47. Papadopoulos N.M., and Kintzios J.A. Quantitative electrophoretic determination of lactate dehydrogenase isoenzymes. Tech. Bull. Regist. Med. Technol. 36 (1966) 302-305
48. Crook M.A., Earle K., Morocutti A., Yip J., Viberti G., and Pickup J.C. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 17 (1994) 305-310
49. Warren L., Buck C.A., and Tuszynski G.P. Glycopeptide changes and malignant transformation. A possible role for carbohydrate in malignant behaviour. Biochim. Biophys. Acta 516 (1978) 97-127
50. Reddy G.K., and Dhar S.C. Connective tissue metabolism in bone and cartilage of adjuvant arthritic rat. Connect. Tissue Res. 26 (1991) 145-153
51. George J., and Chandrakasan G. Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int. J. Biochem. Cell Biol. 28 (1996) 353-361
52. Venkatesan N., Punithavathi D., and Chandrakasan G. Glycoprotein composition in cyclophosphamide-induced lung fibrosis. Biochim. Biophys. Acta 1407 (1998) 125-134
53. Chandrasekaran L., Seethalakshmi S., Chandrakasan G., and Dhar S.C. Alterations in lung and skin compositions of rat in bleomycin-induced fibrosis. Biochem. Med. Metab. Biol. 38 (1987) 205-212
54. Fraser I.H., Coolbear T., Sarkar M., and Mookerjea S. Increase of sialyltransferase activity in the serum and liver of inflamed rats. Biochim. Biophys. Acta 799 (1984) 102-105
55. Lombart C., Sturgess J., and Schachter H. The effect of turpentine-induced inflammation on rat liver glycosyltransferases and Golgi complex ultrastructure. Biochim. Biophys. Acta 629 (1980) 1-12
56. Scheule R.K., Perkins R.C., Hamilton R., and Holian A. Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am. J. Physiol. 262 (1992) L386-L391
57. Zhang K., Gharaee-Kermani M., McGarry B., Remick D., and Phan S.H. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J. Immunol. 158 (1997) 954-959
58. Lin Y.L., and Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharideinduced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 52 (1997) 465-472
59. Yang F., de Villiers W.J., McClain C.J., and Varilek G.W. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128 (1998) 2334-2340
60. Niebes P., and Ponard G. Stabilization of rat liver lysosomes by (+)-cyanidanol-3 in vivo. Biochem. Pharmacol. 24 (1975) 905-909
61. Woessner Jr. J.F. Catabolism of collagen and non-collagen protein in the rat uterus during post-partum involution. Biochem. J. 83 (1962) 304-314
62. Koblinski J.E., Ahram M., and Sloane B.F. Unraveling the role of proteases in cancer. Clin. Chim. Acta 291 (2000) 113-135
63. Laurent-Matha V., Maruani-Herrmann S., Prébois C., Beaujouin M., Glondu M., Noël A., Alvarez-Gonzalez M.L., Blacher S., Coopman P., Baghdiguian S., Gilles C., Loncarek J., Freiss G., Vignon F., and Liaudet-Coopman E. Catalytically-inactive human cathepsin D triggers fibroblast invasive growth. J. Cell Biol. 168 (2005) 489-499
64. Venkatesan N., Punithavathi D., and Chandrakasan G. Biochemical and connective tissue changes in cyclophosphamide-induced lung fibrosis in rats. Biochem. Pharmacol. 56 (1998) 895-904
65. Grande N.R., Peão1 M.N.D., de Sá C.M., and Águas A.P. Lung fibrosis induced by bleomycin: structural changes and overview of recent advances. Scanning Microsc. 12 (1998) 487-494
66. Davidson K.G., Bersten A.D., Barr H.A., Dowling K.D., Nicholas T.E., and Doyle I.R. Lung function, permeability and surfactant composition in oleic acid-induced acute lung injury in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L1091-L1102
67. Davidson K.G., Bersten A.D., Barr H.A., Dowling K.D., Nicolas T.E., and Doyle I.R. Endotoxin induces respiratory failure and increases surfactant turnover and respiration independent of alveolocapillary injury in rats. Am. J. Respir. Crit. Care Med. 165 (2002) 1516-1525
68. Burkhardt A., Holtje W.J., and Gebbers J.O. Vascular lesions following perfusion with bleomycin: electron-microscopic observations. Virchows Arch. A Pathol. Anat. Histol. 372 (1976) 227-236
69. Takabatake N., Arao T., Sata M., Abe S., Inouse S., Shibata Y., Takeshi Y., and Juboto I. Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy. Eur. J. Nucl. Med. Mol. Imaging 32 (2005) 221-228